Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | PPARD | Q03181 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | FDPS | P14324 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | BTN3A1 | O00481 | 3/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.38 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.38 |
| ▸ | MVD | P53602 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29056130 | 0.95 | TSHR (0.55) | TSHRPPARDTDP1FDPSBLM | |
| SCHEMBL627985 | 0.95 | TSHR (0.60) | TSHRPPARDTDP1FDPSBLM | |
| Ammonia Solution, Strong SCHEMBL29191386 | 0.93 | TSHR (0.52) | TSHRPPARDTDP1FDPSBLM | |
| Ammonia Solution, Strong SCHEMBL628388 | 0.92 | TSHR (0.57) | TSHRPPARDTDP1FDPSBLM | |
| Ammonia Solution, Strong SCHEMBL628385 | 0.92 | TSHR (0.57) | TSHRPPARDTDP1FDPSBLM | |
| Ethylene Glycol SCHEMBL29066338 | 0.88 | PPARD (0.56) | TSHRPPARDTDP1FDPSBLM | |
| SCHEMBL27830727 | 0.88 | TSHR (0.52) | TSHRPPARDTDP1FDPSBLM | |
| SCHEMBL27372192 | 0.88 | TSHR (0.52) | TSHRPPARDTDP1FDPSBLM | |
| SCHEMBL28287397 | 0.86 | TSHR (0.50) | TSHRPPARDTDP1FDPSBLM | |
| Phosphoric Acid SCHEMBL27882561 | 0.86 | TSHR (0.50) | TSHRPPARDTDP1FDPSBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104225676-B | Containing the application in osteochondral defect is repaired of the lithium nature material bioactive bracket | 浙江大学 | 2016-08-24 | — | — | CN | claimed |
| CN-104415668-A | Making method of organic-inorganic hybrid separating membrane | DALIAN CHEMICAL PHYSICS INST | 2015-03-18 | — | — | CN | claimed |
| CN-104225676-A | Application of lithium-containing natural material bioactive scaffold in osteochondral defect repair | UNIV ZHEJIANG | 2014-12-24 | — | — | CN | claimed |
| CN-101843919-A | Method for preparing hydroxyapatite/composite hole bioactive glass | UNIV HARBIN NORMAL | 2010-09-29 | — | — | CN | claimed |
| WO-2023185158-A1 | PROCESSING APPARATUS FOR VACUUM HEAT-INSULATING PLATE, AEROGEL-MODIFIED POLYURETHANE FOAM THERMAL INSULATION PLATE, AND PREPARATION METHOD THEREFOR | 重庆再升科技股份有限公司 | 2023-10-05 | — | — | WO | disclosed |
| CN-109355664-A | A kind of copper surface phosphoric acid esters assembles concentration and its application | 上海电力学院 | 2019-02-19 | — | — | CN | disclosed |
| CN-106633011-A | Reaction type flame-retardant polyester polyol and preparation method thereof | 山东诺威聚氨酯股份有限公司 | 2017-05-10 | — | — | CN | disclosed |
| CN-104225676-B | Containing the application in osteochondral defect is repaired of the lithium nature material bioactive bracket | 浙江大学 | 2016-08-24 | — | — | CN | disclosed |
| CN-104415668-A | Making method of organic-inorganic hybrid separating membrane | DALIAN CHEMICAL PHYSICS INST | 2015-03-18 | — | — | CN | disclosed |
| CN-104225676-A | Application of lithium-containing natural material bioactive scaffold in osteochondral defect repair | UNIV ZHEJIANG | 2014-12-24 | — | — | CN | disclosed |
| US-20100324280-A1 | SODIUM ABSORPTION INHIBITOR, POTASSIUM ABSORPTION INHIBITOR, PHOSPHORUS ABSORPTION INHIBITOR AND PREVENTIVE AGENT, THERAPEUTIC AGENT AND FOOD CONTAINING THE SAME | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2010-12-23 | — | — | US | disclosed |
| US-7807653-B2 | Nucleotide mimics and their prodrugs | BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) | 2010-10-05 | — | — | US | disclosed |
| CN-101843919-A | Method for preparing hydroxyapatite/composite hole bioactive glass | UNIV HARBIN NORMAL | 2010-09-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324280-A1 | SODIUM ABSORPTION INHIBITOR, POTASSIUM ABSORPTION INHIBITOR, PHOSPHORUS ABSORPTION INHIBITOR AND PREVENTIVE AGENT, THERAPEUTIC AGENT AND FOOD CONTAINING THE SAME | SLC20A1, ALPI, SLC34A1 | TSHR 1678/4885PPARD 4387/4885TDP1 3691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.